MYGN logo
MYGN NASDAQ US

Myriad Genetics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 1995
$4.75
▲ +$0.16 (+3.49%)
Vol 1.1M
6
Quality Score
fail
Mkt Cap
$573.3M
ROE
-73.9%
Margin
-48.5%
D/E
32.05
Beta
1.89
52W
$4–$15

Wall Street Consensus

18 analysts · Apr 2026
0
Strong Buy
3
Buy
9
Hold
3
Sell
3
Strong Sell
16.7%
Buy Rating

Price Chart

Similar Stocks

IMMX
Immix Biopharma Inc
$275.6M
ABSI
Absci Corp
$524.8M
ASMB
Assembly Biosciences Inc
$537.9M
STTK
Shattuck Labs Inc
$231.0M
RGNX
Regenxbio Inc
$729.0M
ALT
Altimmune Inc
$376.7M
LXEO
Lexeo Therapeutics Inc
$724.8M
AURA
Aura Biosciences Inc
$346.1M
VNDA
Vanda Pharmaceuticals Inc
$521.2M

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.01 $0.04 +$0.05
Sep 2025 $-0.01 $0.00 +$0.01
Jun 2025 $-0.01 $0.05 +$0.06
Mar 2025 $-0.06 $-0.03 +$0.03

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -62.6% -17.4% -62.6% -62.6% -73.9% -73.9%
P/E (TTM) — — — — — —
Net Margin -155.1% -47.5% -47.4% -47.4% -48.5% -48.5%
Gross Margin 71.2% 70.4% 70.4% 70.4% 70.4% 70.4%
D/E Ratio 15.31 5.65 15.21 15.21 32.05 32.05
Current Ratio 1.42 1.82 1.42 1.42 2.33 2.33

Key Ratios

ROA (TTM)
-46.6%
P/S (TTM)
0.69
P/B
1.8
EPS (TTM)
$-4.34
CF/Share
$-2.62
Rev Growth 3Y
+6.6%
52W High
$15.47
52W Low
$3.76
$3.76 52-Week Range $15.47

How does MYGN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MYGN AAPG ABEO ABOS ABP

MYGN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.7
▼ 95% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.8
▼ 28% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MYGN profitability vs Biotechnology peers

ROE
-73.9%
▼ 10% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-48.5%
▲ 83% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
70.4%
▼ 10% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-46.6%
▲ 0% above peers (-46.7%)
vs Peers
vs Industry
In line

MYGN financial health vs Biotechnology peers

D/E ratio
32.1
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
2.3
▼ 48% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.9
▲ 95% above peers (1.0)
vs Peers
vs Industry
More volatile

MYGN fundamentals radar

MYGN Peer median Industry

MYGN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MYGN vs peers: key metrics

Latest News

No related news yet